Rhodia, Cobalt Technologies to Develop and Operate Biobutanol Demonstration Plant in Brazil

Specialty chemical company Rhodia, a member of the Solvay Group, and Cobalt Technologies, a developer of advanced bio-based chemicals, have announced that they will jointly develop and operate a biobutanol demonstration plant in Brazil. In Latin America, Brazilian bagasse and other non-food feedstock will be converted into bio n-butanol using Cobalt's technology. Butanol is employed as an industrial chemical in solvents, paints, adhesives and inks.

Bob Mayer, CEO of Cobalt Technologies, stated that they are pleased to work with Rhodia to develop the first commercial-scale biorefinery to produce biobutanol using bagasse as a feedstock. Mayer added that this joint venture will help them to succeed in the Latin American market.

Rhodia and Cobalt will be building and operating the biobutanol demonstration facility, which will corroborate Cobalt's technology and its capacity to combine with present sugar mills in Brazil. Construction will begin in August 2012 and they will start integration testing by moving to the mill site in early 2013. By mid 2013, operational testing at the demonstration facility plant is likely to be completed.

Vincent Kamel, President of Rhodia Coatis Business Unit, stated that they are convinced that over the long term, Cobalt's technology will deliver unprecedented benefit, thereby improving their development plans towards their Augeo range of biosourced solvents. He added that they are looking forward to capitalize on the market opportunity for bio n-butanol in Latin America and other countries while working closely with Cobalt.

Both the companies in the past nine months investigated opportunities for integrating existing sugar mills with Cobalt's technology. The feasibility phase validated the attractive economics and scalability of Cobalt's biomass processing and next-generation fermentation technology, and also the feasibility to work with  local biomass in Brazil. These aspects prompted both the companies to sign the Term Sheet and strengthen their relationship.

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

G.P. Thomas

Written by

G.P. Thomas

Gary graduated from the University of Manchester with a first-class honours degree in Geochemistry and a Masters in Earth Sciences. After working in the Australian mining industry, Gary decided to hang up his geology boots and turn his hand to writing. When he isn't developing topical and informative content, Gary can usually be found playing his beloved guitar, or watching Aston Villa FC snatch defeat from the jaws of victory.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, G.P.. (2019, February 09). Rhodia, Cobalt Technologies to Develop and Operate Biobutanol Demonstration Plant in Brazil. AZoM. Retrieved on November 22, 2024 from https://www.azom.com/news.aspx?newsID=33749.

  • MLA

    Thomas, G.P.. "Rhodia, Cobalt Technologies to Develop and Operate Biobutanol Demonstration Plant in Brazil". AZoM. 22 November 2024. <https://www.azom.com/news.aspx?newsID=33749>.

  • Chicago

    Thomas, G.P.. "Rhodia, Cobalt Technologies to Develop and Operate Biobutanol Demonstration Plant in Brazil". AZoM. https://www.azom.com/news.aspx?newsID=33749. (accessed November 22, 2024).

  • Harvard

    Thomas, G.P.. 2019. Rhodia, Cobalt Technologies to Develop and Operate Biobutanol Demonstration Plant in Brazil. AZoM, viewed 22 November 2024, https://www.azom.com/news.aspx?newsID=33749.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.